Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01539096 · ClinicalTrials.gov registry record · Phase 1
Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery
A Phase 1 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT01539096: Completed Phase 1 study, sponsored by The Cleveland Clinic.
NCT01539096 is a Phase 1 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 67 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (12% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01539096, a Phase 1 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether benefits of training the affected hand in patients with stroke can be improved by combining training with a painless, noninvasive technique called Transcranial Direct Current Stimulation (TDCS). TDCS will be applied over the part of the brain responsible for movements of the affected hand. Also, the investigators will study the changes in the brain that favor recovery of hand function following combination of training and tDCS.
Primary Outcome
To address the functional advantage of combining tDCS and CIMT tests that evaluate impairments of the hand will be utilized. Also, change in ability to carry out activities of daily living will be measured.
Interventions
- BEHAVIORAL Constraint induced movement therapy (CIMT)
- PROCEDURE Sham tDCS: placebo noninvasive brain stimulation
- PROCEDURE tDCS: noninvasive brain stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2011-07 |
| Est. Completion | 2019-12 |
| Phase | Phase 1 |
What the finished NCT01539096 record still lists
NCT01539096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (12% higher).
The record links to 0 conditions, and to 3 interventions - of which Constraint induced movement therapy (CIMT) is the first listed.
NCT01539096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01539096 about?
NCT01539096 is a clinical study titled "Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery". The purpose of this study is to investigate whether benefits of training the affected hand in patients with stroke can be improved by combining training with a painless, noninvasive technique called Transcranial Direct Current Stimulation (TDCS). TDCS will be applied over the part of the brain respo...
What is the current status of trial NCT01539096?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2011-07. Estimated completion is 2019-12.
What interventions are being tested in trial NCT01539096?
The interventions under investigation include: Constraint induced movement therapy (CIMT) (BEHAVIORAL), Sham tDCS: placebo noninvasive brain stimulation (PROCEDURE), tDCS: noninvasive brain stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT01539096?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01539096's enrollment target sits among peer trials
67 782nd of 2000 higher than 1,215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia